Cardiovascular drug delivery with ultrasound and microbubbles

Advanced Drug Delivery Reviews

Volumn 72, Issue , 2014, Pages 110-126

  Unger, Evan ^a   Porter, Thomas ^b   Lindner, Jonathan ^c   Grayburn, Paul ^d  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d Baylor Heart Vascular Institute   (United States)

Author keywords

Cardiovascular; Drug delivery; Fluorocarbons; Gene delivery; Microbubbles; Oxygen delivery; Perfluorobutane; Perfluoropentane; Perfluoropropane; Sonothrombolysis; Ultrasound

Indexed keywords

CONTROLLED DRUG DELIVERY; DRUG DELIVERY; ENDOTHELIAL CELLS; FLUOROCARBONS; GENE EXPRESSION; GENE TRANSFER; MOLECULAR IMAGING; ULTRASONICS;

CARDIOVASCULAR; GENE DELIVERY; MICROBUBBLES; OXYGEN DELIVERY; PERFLUOROBUTANE; PERFLUOROPENTANE; PERFLUOROPROPANE; SONOTHROMBOLYSIS;

TARGETED DRUG DELIVERY;

CONTRAST MEDIUM; DRUG CARRIER; EPITOPE; NEUROPROTECTIVE AGENT; OXYGEN; PERFLUOROPENTANE; CARDIOVASCULAR AGENT; FLUOROCARBON;

BLOOD CLOT LYSIS; CARDIOVASCULAR DRUG DELIVERY; CARDIOVASCULAR SYSTEM; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG TARGETING; ENDOTHELIUM; HEART INFARCTION; HUMAN; LEUKOCYTE; MICROBUBBLE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PHAGOCYTE; PRIORITY JOURNAL; RADIATION FORCE; RADIOLOGICAL PARAMETERS; REVIEW; SONOTHROMBOLYSIS; ULTRASOUND; ULTRASOUND TARGETED MICROBUBBLE DESTRUCTION; ANIMAL; GENE TRANSFER; MECHANICAL THROMBECTOMY; PROCEDURES;

ANIMALS; CARDIOVASCULAR AGENTS; DRUG DELIVERY SYSTEMS; FLUOROCARBONS; GENE TRANSFER TECHNIQUES; HUMANS; MECHANICAL THROMBOLYSIS; MICROBUBBLES; OXYGEN; ULTRASONICS;

EID: 84901633696     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2014.01.012     Document Type: Review

References (139)

1. Main M.L., Hibberd M.G., Ryan A., Lowe T.J., Miller P., Bhat G. Acute mortality in critically ill patients undergoing echocardiography with or without an ultrasound contrast agent. JACC Cardiovasc. Imaging 2013.
2. Barr R.G. Off-label use of ultrasound contrast agents for abdominal imaging in the United States. J. Ultrasound Med. 2013, 32:7-12.
3. Piscaglia F., Nolsøe C., Dietrich C., Cosgrove D., Gilja O., Bachmann Nielsen M., Albrecht T., Barozzi L., Bertolotto M., Catalano O. The EFSUMB guidelines and recommendations on the clinical practice of contrast enhanced ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med. 2012, 33:33.
4. Claudon M., Dietrich C.F., Choi B.I., Cosgrove D.O., Kudo M., Nolsøe C.P., Piscaglia F., Wilson S.R., Barr R.G., Chammas M.C. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver-update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med. Biol. 2012.
5. Azmin M., Harfield C., Ahmad Z., Edirisinghe M., Stride E. How do microbubbles and ultrasound interact? Basic physical, dynamic and engineering principles. Curr. Pharm. Des. 2012, 18:2118-2134.
6. Faez T., Emmer M., Kooiman K., Versluis M., van der Steen A.F., de Jong N. 20years of ultrasound contrast agent modeling. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 2013, 60:7-20.
7. Stride E. Physical principles of microbubbles for ultrasound imaging and therapy. Cerebrovasc. Dis. 2009, 27:1-13.
8. Janib S.M., Moses A.S., MacKay J.A. Imaging and drug delivery using theranostic nanoparticles. Adv. Drug Deliv. Rev. 2010, 62:1052-1063.
9. Kiessling F., Fokong S., Koczera P., Lederle W., Lammers T. Ultrasound microbubbles for molecular diagnosis, therapy, and theranostics. J. Nucl. Med. 2012, 53:345-348.
10. Johnson J.L.H., Leos R.A., Baker A.F., Unger E.C. Radiation sensitization for Hs-766T pancreatic tumor xenografts in mice dosed with dodecafluropentane nano emulsion. J. Biomed. Nanotechnol. 2014, (in press).
11. Swanson E.J., Mohan V., Kheir J., Borden M.A. Phospholipid-stabilized microbubble foam for injectable oxygen delivery. Langmuir 2010, 26:15726-15729.
12. Grayburn P.A., Weiss J.L., Hack T.C., Klodas E., Raichlen J.S., Vannan M.A., Klein A.L., Kitzman D.W., Chrysant S.G., Cohen J.L. Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms. J. Am. Coll. Cardiol. 1998, 32:230-236.
13. Correas J.-M., Meuter A.R., Singlas E., Kessler D.R., Worah D., Quay S.C. Human pharmacokinetics of a perfluorocarbon ultrasound contrast agent evaluated with gas chromatography. Ultrasound Med. Biol. 2001, 27:565-570.
14. Forsberg F., Roy R., Merton D.A., Rawool N.M., Liu J.-B., Huang M., Kessler D., Goldberg B.B. Conventional and hypobaric activation of an ultrasound contrast agent. Ultrasound Med. Biol. 1998, 24:1143-1150.
15. http://www.ema.europa.eu/docs/en_GB/document_library?Public_statement/2009/12/WC.
16. Luo W., Numata K., Kondo M., Morimoto M., Sugimori K., Hirasawa K., Nozaki A., Zhou X., Tanaka K. Sonazoid-enhanced ultrasonography for evaluation of the enhancement patterns of focal liver tumors in the late phase by intermittent imaging with a high mechanical index. J. Ultrasound Med. 2009, 28:439-448.
17. Seidel G.T., Meyer K., Algermissen C., Broillet A. Harmonic imaging of the brain parenchyma using a perfluorobutane-containing ultrasound contrast agent. Ultrasound Med. Biol. 2001, 27:915-918.
18. Pochon S., Tardy I., Bussat P., Bettinger T., Brochot J., von Wronski M., Passantino L., Schneider M. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis. Invest. Radiol. 2010, 45:89-95.
19. http://www.definityimaging.com.
20. http://optisonimaging.com.
21. Sontum P.C. Physicochemical characteristics of Sonazoid™, a new contrast agent for ultrasound imaging. Ultrasound Med. Biol. 2008, 34:824-833.
22. Schneider M. SonoVue, a new ultrasound contrast agent. Eur. Radiol. 1999, 9:S347.
23. R. Walovitch, H. Bernstein, D. Chickering, J. Straub, Ultrasound contrast agent dosage formulation, in, Google Patents, 2011.
24. http://www.acusphere.com/product/home.html.
25. Kabalnov A., Klein D., Pelura T., Schutt E., Weers J. Dissolution of multicomponent microbubbles in the bloodstream: 1. Theory. Ultrasound Med. Biol. 1998, 24:739-749.
26. Hampton M.B., Vissers M.C., Keenan J.I., Winterbourn C.C. Oxidant-mediated phosphatidylserine exposure and macrophage uptake of activated neutrophils: possible impairment in chronic granulomatous disease. J. Leukoc. Biol. 2002, 71:775-781.
27. Faez T., Goertz D., De Jong N. Characterization of Definity™ ultrasound contrast agent at frequency range of 5-15MHz. Ultrasound Med. Biol. 2011, 37:338-342.
28. Goertz D.E., de Jong N., van der Steen A.F. Attenuation and size distribution measurements of Definity™ and manipulated Definity™ populations. Ultrasound Med. Biol. 2007, 33:1376-1388.
29. Dahneke B.E. Measurement of Suspended Particles by Quasi-Elastic Light Scattering 1983, John Wiley & Sons.
30. Driscoll D.F., Etzler F., Barber T.A., Nehne J., Niemann W., Bistrian B.R. Physicochemical assessments of parenteral lipid emulsions: light obscuration versus laser diffraction. Int. J. Pharm. 2001, 219:21-37.
31. Driscoll D. Examination of selection of light-scattering and light-obscuration acceptance criteria for lipid injectable emulsions. Pharmacopeial Forum 2004, 2-11.
32. Driscoll D.F. Lipid injectable emulsions: pharmacopeial and safety issues. Pharm. Res. 2006, 23:1959-1969.
33. US Pharmacopoeidal Forum. Vol 31. No.5. 2005.
34. Church C.C., Carstensen E.L. "Stable" inertial cavitation. Ultrasound Med. Biol. 2001, 27:1435-1437.
35. Karshafian R., Bevan P.D., Williams R., Samac S., Burns P.N. Sonoporation by ultrasound-activated microbubble contrast agents: effect of acoustic exposure parameters on cell membrane permeability and cell viability. Ultrasound Med. Biol. 2009, 35:847-860.
36. Ohl C.-D., Arora M., Ikink R., de Jong N., Versluis M., Delius M., Lohse D. Sonoporation from jetting cavitation bubbles. Biophys. J. 2006, 91:4285-4295.
37. Lum A.F., Borden M.A., Dayton P.A., Kruse D.E., Simon S.I., Ferrara K.W. Ultrasound radiation force enables targeted deposition of model drug carriers loaded on microbubbles. J. Control. Release 2006, 111:128-134.
38. Dayton P., Klibanov A., Brandenburger G., Ferrara K. Acoustic radiation force in vivo: a mechanism to assist targeting of microbubbles. Ultrasound Med. Biol. 1999, 25:1195-1201.
39. Unger E., Matsunaga T. Gene Delivery with Ultrasound and Microbubbles 2011, INTECH, Non-Viral Gene Therapy.
40. Unger E.C., McCreery T.P., Sweitzer R.H., Caldwell V.E., Wu Y. Acoustically active lipospheres containing paclitaxel: a new therapeutic ultrasound contrast agent. Invest. Radiol. 1998, 33:886-892.
41. Capan Y., Woo B.H., Gebrekidan S., Ahmed S., DeLuca P.P. Influence of formulation parameters on the characteristics of poly (d, l-lactide-co-glycolide) microspheres containing poly (l-lysine) complexed plasmid DNA. J. Control. Release 1999, 60:279-286.
42. Hauff P., Seemann S., Reszka R., Schultze-Mosgau M., Reinhardt M., Buzasi T., Plath T., Rosewicz S., Schirner M. Evaluation of gas-filled microparticles and sonoporation as gene delivery system: feasibility study in rodent tumor models. Radiology 2005, 236:572-578.
43. Sirsi S.R., Hernandez S.L., Zielinski L., Blomback H., Koubaa A., Synder M., Homma S., Kandel J.J., Yamashiro D.J., Borden M.A. Polyplex-microbubble hybrids for ultrasound-guided plasmid DNA delivery to solid tumors. J. Control. Release 2012, 157:224-234.
44. Sirsi S.R., Yamashiro D., Kandel J., Borden M. Polyplex-microbubbles for ultrasound-mediated gene therapy. Proceedings of Meetings on Acoustics 2013, 075058.
45. Jin Q., Wang Z., Yan F., Deng Z., Ni F., Wu J., Shandas R., Liu X., Zheng H. A novel cationic microbubble coated with stearic acid-modified polyethylenimine to enhance DNA loading and gene delivery by ultrasound. PLoS One 2013, 8:e76544.
46. Burke C.W., Alexander E., Timbie K., Kilbanov A.L., Price R.J. Ultrasound-activated agents comprised of 5FU-bearing nanoparticles bonded to microbubbles inhibit solid tumor growth and improve survival. Mol. Ther. 2014, 22(2):321-328.
47. Park J.I., Jagadeesan D., Williams R., Oakden W., Chung S., Stanisz G.J., Kumacheva E. Microbubbles loaded with nanoparticles: a route to multiple imaging modalities. ACS Nano 2010, 4:6579-6586.
48. Klibanov A.L., Shevchenko T.I., Raju B.I., Seip R., Chin C.T. Ultrasound-triggered release of materials entrapped in microbubble-liposome constructs: a tool for targeted drug delivery. J. Control. Release 2010, 148:13-17.
49. Go A.S., Mozaffarian D., Roger V.L., Benjamin E.J., Berry J.D., Borden W.B., Bravata D.M., Dai S., Ford E.S., Fox C.S. Heart disease and stroke statistics-2013 update a report from the American Heart Association. Circulation 2013, 127:e6-e245.
50. Unger E.C., et al. Therapeutic applications of lipid-coated microbubbles. Adv. Drug Deliv. Rev. 2004, 56.9:1291-1314.
51. Hölscher T., et al. In vitro sonothrombolysis with duplex ultrasound: first results using a simplified model. Cerebrovasc. Dis. 2009, 28.4:365-370.
52. Hagisawa K., et al. Thrombus-targeted perfluorocarbon-containing liposomal bubbles for enhancement of ultrasonic thrombolysis: in vitro and in vivo study. J. Thromb. Haemost. 2013, 11.8:1565-1573.
53. de Saint Victor M., et al. Properties, characteristics and applications of microbubbles for sonothrombolysis. Expert opinion on drug delivery 2014, 1-23.
54. Alonso A., et al. In vivo clot lysis of human thrombus with intravenous abciximab immunobubbles and ultrasound. Thromb. Res. 2009, 124.1:70-74.
55. Molina C.A., Barreto A.D., Tsivgoulis G., Sierzenski P., Malkoff M.D., Rubiera M., Gonzales N., Mikulik R., Pate G., Ostrem J. Transcranial ultrasound in clinical sonothrombolysis (TUCSON) trial. Ann. Neurol. 2009, 66:28-38.
56. Chen X., et al. New Insights into Mechanisms of Sonothrombolysis Using Ultra-High-Speed Imaging. Ultrasound Med. Biol. 2014, 40.1:258-262.
57. Alexandrov A.V., Molina C.A., Grotta J.C., Garami Z., Ford S.R., Alvarez-Sabin J., Montaner J., Saqqur M., Demchuk A.M., Moyé L.A. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N. Engl. J. Med. 2004, 351:2170-2178.
58. Adams H.P., Adams R.J., Brott T., del Zoppo G.J., Furlan A., Goldstein L.B., Grubb R.L., Higashida R., Kidwell C., Kwiatkowski T.G. Guidelines for the early management of patients with ischemic stroke a scientific statement from the stroke council of the American stroke association. Stroke 2003, 34:1056-1083.
59. Adams H.P., del Zoppo G., Alberts M.J., Bhatt D.L., Brass L., Furlan A., Grubb R.L., Higashida R.T., Jauch E.C., Kidwell C. Guidelines for the early management of adults with ischemic stroke a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 2007, 115:e478-e534.
60. Hacke W., Kaste M., Bluhmki E., Brozman M., Dávalos A., Guidetti D., Larrue V., Lees K.R., Medeghri Z., Machnig T. Thrombolysis with alteplase 3 to 4.5hours after acute ischemic stroke. N. Engl. J. Med. 2008, 359:1317-1329.
61. Kleindorfer D., Xu Y., Moomaw C.J., Khatri P., Adeoye O., Hornung R. US geographic distribution of rt-PA utilization by hospital for acute ischemic stroke. Stroke 2009, 40:3580-3584.
62. Wang D.Z., Rose J.A., Honings D.S., Garwacki D.J., Milbrandt J.C. Treating acute stroke patients with intravenous t-PA the OSF stroke network experience. Stroke 2000, 31:77-81.
63. Molina C.A., Ribo M., Rubiera M., Montaner J., Santamarina E., Delgado-Mederos R., Arenillas J.F., Huertas R., Purroy F., Delgado P. Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator. Stroke 2006, 37:425-429.
64. Alexandrov A.V., Mikulik R., Ribo M., Sharma V.K., Lao A.Y., Tsivgoulis G., Sugg R.M., Barreto A., Sierzenski P., Malkoff M.D. A pilot randomized clinical safety study of sonothrombolysis augmentation with ultrasound-activated perflutren-lipid microspheres for acute ischemic stroke. Stroke 2008, 39:1464-1469.
65. Meairs S., Culp W. Microbubbles for thrombolysis of acute ischemic stroke. Cerebrovasc. Dis. 2009, 27:55-65.
66. Brown A.T., Flores R., Hamilton E., Roberson P.K., Borrelli M.J., Culp W.C. Microbubbles improve sonothrombolysis in vitro and decrease hemorrhage in vivo in a rabbit stroke model. Investig. Radiol. 2011, 46:202-207.
67. Culp W.C., Flores R., Brown A.T., Lowery J.D., Roberson P.K., Hennings L.J., Woods S.D., Hatton J.H., Culp B.C., Skinner R.D. Successful microbubble sonothrombolysis without tissue-type plasminogen activator in a rabbit model of acute ischemic stroke. Stroke 2011, 42:2280-2285.
68. Flores R., Hennings L.J., Lowery J.D., Brown A.T., Culp W.C. Microbubble augmented ultrasound sonothrombolysis decreases intracranial hemorrhage in a rabbit model of acute ischemic stroke. Invest. Radiol. 2011, 46:419.
69. Lapchak P.A., Kikuchi K., Butte P., Hölscher T. Development of transcranial sonothrombolysis as an alternative stroke therapy: incremental scientific advances toward overcoming substantial barriers. Expert Rev. Med. Devices 2013, 10:201-213.
70. Daffertshofer M., Gass A., Ringleb P., Sitzer M., Sliwka U., Els T., Sedlaczek O., Koroshetz W.J., Hennerici M.G. Transcranial low-frequency ultrasound-mediated thrombolysis in brain ischemia increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator: results of a phase II clinical trial. Stroke 2005, 36:1441-1446.
71. Bor-Seng-Shu E., De Carvalho Nogueira R., Figueiredo E.G., Evaristo E.F., Conforto A.B., Teixeira M.J. Sonothrombolysis for acute ischemic stroke: a systematic review of randomized controlled trials. Neurosurg. Focus 2012, 32:E5.
72. Eggers J., König I.R., Koch B., Händler G., Seidel G. Sonothrombolysis with transcranial color-coded sonography and recombinant tissue-type plasminogen activator in acute middle cerebral artery main stem occlusion results from a randomized study. Stroke 2008, 39:1470-1475.
73. Burgess A., Huang Y., Waspe A.C., Ganguly M., Goertz D.E., Hynynen K. High-intensity focused ultrasound (HIFU) for dissolution of clots in a rabbit model of embolic stroke. PLoS One 2012, 7:e42311.
74. http://clinicaltrials.gov/show/NCT01098981.
75. Davies M.J., Thomas A.C. Plaque fissuring-the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br. Heart J. 1985, 53:363.
76. Suryapranata H., van't Hof A.W., Hoorntje J.C., de Boer M.-J., Zijlstra F. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation 1998, 97:2502-2505.
77. Morishima I., Sone T., Mokuno S., Taga S., Shimauchi A., Oki Y., Kondo J., Tsuboi H., Sassa H. Clinical significance of no-reflow phenomenon observed on angiography after successful treatment of acute myocardial infarction with percutaneous transluminal coronary angioplasty. Am. Heart J. 1995, 130:239-243.
78. Brujan E.-A. Cardiovascular cavitation. Med. Eng. Phys. 2009, 31:742-751.
79. Kutty S., Wu J., Hammel J.M., Xie F., Gao S., Drvol L.K., Lof J., Radio S.J., Therrien S.L., Danford D.A. Microbubble mediated thrombus dissolution with diagnostic ultrasound for the treatment of chronic venous thrombi. PLoS One 2012, 7:e51453.
80. Kutty S., Xie F., Gao S., Drvol L.K., Lof J., Fletcher S.E., Radio S.J., Danford D.A., Hammel J.M., Porter T.R. Sonothrombolysis of intra-catheter aged venous thrombi using microbubble enhancement and guided three-dimensional ultrasound pulses. J. Am. Soc. Echocardiogr. 2010, 23:1001-1006.
81. Xie F., Lof J., Matsunaga T., Zutshi R., Porter T.R. Diagnostic ultrasound combined with glycoprotein IIb/IIIa-targeted microbubbles improves microvascular recovery after acute coronary thrombotic occlusions. Circulation 2009, 119:1378-1385.
82. Xie F., Slikkerveer J., Gao S., Lof J., Kamp O., Unger E., Radio S., Matsunaga T., Porter T.R. Coronary and microvascular thrombolysis with guided diagnostic ultrasound and microbubbles in acute ST segment elevation myocardial infarction. J. Am. Soc. Echocardiogr. 2011, 24:1400-1408.
83. Unger E., Zutshi R., Labell R., Porter T.R., Lof J., Xie F., Ferrara K., Dayton P., Bloch S. Sonothrombolysis with phospholipid-coated perfluoropropane microbubbles. AIP Conference Proceedings 2005, 58.
84. Datta S., Coussios C.-C., Ammi A.Y., Mast T.D., de Courten-Myers G.M., Holland C.K. Ultrasound-enhanced thrombolysis using Definity® as a cavitation nucleation agent. Ultrasound Med. Biol. 2008, 34:1421-1433.
85. Slikkerveer J., Kleijn S.A., Appelman Y., Porter T.R., Veen G., van Rossum A.C., Kamp O. Ultrasound enhanced prehospital thrombolysis using microbubbles infusion in patients with acute ST elevation myocardial infarction: pilot of the Sonolysis study. Ultrasound Med. Biol. 2012, 38:247-252.
86. Júnior W.M. Therapeutic Use of Ultrasound in an Acute and Chronic Coronary Artery Disease 2013.
87. Moghimi S., Szebeni J. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog. Lipid Res. 2003, 42:463-478.
88. Klibanov A., Rychak J., Yang W., Alikhani S., Li B., Acton S., Lindner J., Ley K., Kaul S. Targeted ultrasound contrast agent for molecular imaging of inflammation in high-shear flow. Contrast Media Mol. Imaging 2006, 1:259-266.
89. Villanueva F.S., Jankowski R.J., Klibanov S., Pina M.L., Alber S.M., Watkins S.C., Brandenburger G.H., Wagner W.R. Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. Circulation 1998, 98:1-5.
90. Kaufmann B.A., Lindner J.R. Molecular imaging with targeted contrast ultrasound. Curr. Opin. Biotechnol. 2007, 18:11-16.
91. Gerrit L., Sijbrands E.J., Folkert J., Feinstein S.B., van der Steen PhD A.F., Daemen M.J., Schinkel A.F. Molecular imaging of inflammation and intraplaque vasa vasorum: a step forward to identification of vulnerable plaques?. J. Nucl. Cardiol. 2010, 17:897-912.
92. Hyvelin J-M., et al. Ultrasound Molecular Imaging of Transient Acute Myocardial Ischemia With a Clinically Translatable P-and E-Selectin Targeted Contrast Agent: Correlation With the Expression of Selectins. Invest. Radiol. 2014.
93. Lindner J.R. Molecular imaging of myocardial and vascular disorders with ultrasound. JACC Cardiovasc. Imaging 2010, 3:204-211.
94. McCarty O.J., Conley R.B., Shentu W., Tormoen G.W., Zha D., Xie A., Qi Y., Zhao Y., Carr C., Belcik T. Molecular imaging of activated von Willebrand factor to detect high-risk atherosclerotic phenotype. JACC Cardiovasc. Imaging 2010, 3:947-955.
95. Wu Y., Unger E.C., McCreery T.P., Sweitzer R.H., Shen D., Wu G., Vielhauer M.D. Binding and lysing of blood clots using MRX-408. Invest. Radiol. 1998, 33:880-885.
96. Lindner J.R., Song J., Xu F., Klibanov A.L., Singbartl K., Ley K., Kaul S. Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytes. Circulation 2000, 102:2745-2750.
97. Utsugi T., Schroit A.J., Connor J., Bucana C.D., Fidler I.J. Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes. Cancer Res. 1991, 51:3062-3066.
98. Koopman G., Reutelingsperger C., Kuijten G., Keehnen R., Pals S., Van Oers M. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994, 84:1415-1420.
99. Unger E.C., McCreery T.P., Sweitzer R.H., Shen D., Wu G. In vitro studies of a new thrombus-specific ultrasound contrast agent. Am. J. Cardiol. 1998, 81:58G-61G.
100. Unger E., Metzger P., Krupinski E., Baker M., Hulett R., Gabaeff D., Mills J., Ihnat D., McCreery T. The use of a thrombus-specific ultrasound contrast agent to detect thrombus in arteriovenous fistulae. Invest. Radiol. 2000, 35:86.
101. Hua X., Liu P., Gao Y.-H., Tan K.-B., Zhou L.-N., Liu Z., Li X., Zhou S.-W., Gao Y.-J. Construction of thrombus-targeted microbubbles carrying tissue plasminogen activator and their in vitro thrombolysis efficacy: a primary research. J. Thromb. Thrombolysis 2010, 30:29-35.
102. Davidson B.P., Kaufmann B.A., Belcik J.T., Xie A., Qi Y., Lindner J.R. Detection of antecedent myocardial ischemia with multiselectin molecular imaging. J. Am. Coll. Cardiol. 2012, 60:1690-1697.
103. Unger E.C., Marinelli E., El Mehdi D., Williams S., Touroo J., Kaplan H., Johnson J.L.H. E-selectin targeted nanocomposites for imaging uveitis. The 27th Annual Advances in Contrast Ultrasound, September 21, 2012, Chicago, Illinois 2012.
104. Lindner J.R. Molecular imaging of vascular phenotype in cardiovascular disease: new diagnostic opportunities on the horizon. J. Am. Soc. Echocardiogr. 2010, 23:343-350.
105. Thomas C.E., Ehrhardt A., Kay M.A. Progress and problems with the use of viral vectors for gene therapy. Nat. Rev. Genet. 2003, 4:346-358.
106. Hacein-Bey-Abina S., Von Kalle C., Schmidt M., McCormack M., Wulffraat N., Leboulch P., Lim A., Osborne C., Pawliuk R., Morillon E. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003, 302:415-419.
107. Unger E.C., McCreery T.P., Sweitzer R.H. Ultrasound enhances gene expression of liposomal transfection. Invest. Radiol. 1997, 32:723-727.
108. E.C. Unger, T.A. Fritz, T. Matsunaga, V. Ramaswami, D. Yellowhair, G. Wu, Therapeutic delivery systems related applications, in, Google Patents, 1996.
109. Shohet R.V., Chen S., Zhou Y.-T., Wang Z., Meidell R.S., Unger R.H., Grayburn P.A. Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation 2000, 101:2554-2556.
110. E.C. Unger, T. McCreery, Methods for delivering compounds into a cell, in, Google Patents, 2004.
111. Anwer K., Kao G., Proctor B., Anscombe I., Florack V., Earls R., Wilson E., McCreery T., Unger E., Rolland A. Ultrasound enhancement of cationic lipid-mediated gene transfer to primary tumors following systemic administration. Gene Ther. 2000, 7:1833-1839.
112. Chen S., Ding J.-H., Bekeredjian R., Yang B.-Z., Shohet R.V., Johnston S.A., Hohmeier H.E., Newgard C.B., Grayburn P.A. Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology. Proc. Natl. Acad. Sci. 2006, 103:8469-8474.
113. Fujii H., Li S.-H., Wu J., Miyagi Y., Yau T.M., Rakowski H., Egashira K., Guo J., Weisel R.D., Li R.-K. Repeated and targeted transfer of angiogenic plasmids into the infarcted rat heart via ultrasound targeted microbubble destruction enhances cardiac repair. Eur. Heart J. 2011, 32:2075-2084.
114. Suzuki J.-I., Ogawa M., Takayama K., Taniyama Y., Morishita R., Hirata Y., Nagai R., Isobe M. Ultrasound-microbubble-mediated intercellular adhesion molecule-1 small interfering ribonucleic acid transfection attenuates neointimal formation after arterial injury in mice. J. Am. Coll. Cardiol. 2010, 55:904-913.
115. Nomikou N., Tiwari P., Trehan T., Gulati K., McHale A.P. Studies on neutral, cationic and biotinylated cationic microbubbles in enhancing ultrasound-mediated gene delivery in vitro and in vivo. Acta Biomater. 2012, 8:1273-1280.
116. Fujii H., Sun Z., Li S.-H., Wu J., Fazel S., Weisel R.D., Rakowski H., Lindner J., Li R.-K. Ultrasound-targeted gene delivery induces angiogenesis after a myocardial infarction in mice. JACC Cardiovasc. Imaging 2009, 2:869-879.
117. Unger E.C., Hersh E., Vannan M., Matsunaga T.O., McCreery T. Local drug and gene delivery through microbubbles. Prog. Cardiovasc. Dis. 2001, 44:45-54.
118. Xie A., Belcik T., Qi Y., Morgan T.K., Champaneri S.A., Taylor S., Davidson B.P., Zhao Y., Klibanov A.L., Kuliszewski M.A. Ultrasound-mediated vascular gene transfection by cavitation of endothelial-targeted cationic microbubbles. JACC Cardiovasc. Imaging 2012, 5:1253-1262.
119. Geis N.A., Mayer C.R., Kroll R.D., Hardt S.E., Katus H.A., Bekeredjian R. Spatial distribution of ultrasound targeted microbubble destruction increases cardiac transgene expression but not capillary permeability. Ultrasound Med. Biol. 2009, 35:1119-1126.
120. Xu Y.-L., Gao Y.-H., Liu Z., Tan K.-B., Hua X., Fang Z.-Q., Wang Y.-L., Wang Y.-J., Xia H.-M., Zhuo Z.-X. Myocardium-targeted transplantation of mesenchymal stem cells by diagnostic ultrasound-mediated microbubble destruction improves cardiac function in myocardial infarction of New Zealand rabbits. Int. J. Cardiol. 2010, 138:182-195.
121. Chen S., Shimoda M., Chen J., Grayburn P. Stimulation of adult resident cardiac progenitor cells by durable myocardial expression of thymosin beta 4 with ultrasound-targeted microbubble delivery. Gene Ther. 2013, 20(2):225-233.
122. Kuliszewski M.A., Kobulnik J., Lindner J.R., Stewart D.J., Leong-Poi H. Vascular gene transfer of SDF-1 promotes endothelial progenitor cell engraftment and enhances angiogenesis in ischemic muscle. Mol. Ther. 2011, 19:895-902.
123. A.D.Association National diabetes fact sheet Internet:, (accessed 20 September 2006). http://www.diabetes.org/uedocuments/NationalDiabetesFactSheetRev.pdf.
124. Grundy S.M., Benjamin I.J., Burke G.L., Chait A., Eckel R.H., Howard B.V., Mitch W., Smith S.C., Sowers J.R. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 1999, 100:1134-1146.
125. Kuller L.H. Stroke and diabetes. Diabetes in America 1995, 2:449-456.
126. Chen S., Shimoda M., Chen J., Matsumodo S., Grayburn P.A. Transient overexpression of cyclin D2/CDK4/GLP1 genes induces proliferation and differentiation of adult pancreatic progenitors and mediates islet regeneration. Cell Cycle 2012, 11:695.
127. Chen S., Shimoda M., Wang M.-Y., Ding J., Noguchi H., Matsumoto S., Grayburn P.A. Regeneration of pancreatic islets in vivo by ultrasound-targeted gene therapy. Gene Ther. 2010, 17:1411-1420.
128. Shimoda M., Chen S., Noguchi H., Matsumoto S., Grayburn P. In vivo non-viral gene delivery of human vascular endothelial growth factor improves revascularisation and restoration of euglycaemia after human islet transplantation into mouse liver. Diabetologia 2010, 53:1669-1679.
129. H.D. Van Liew, M.E. Burkard, C.E. Lundgren, I.M. Tyssebotn, Method for enhancing transport of gases to tissues, in, Google Patents, 1999.
130. C.E. Lundgren, I.M. Tyssebotn, H.D. Van Liew, M.E. Burkard, Method for enhancing transport of gases to tissues, in, Google Patents, 2000.
131. Burkard M.E., Van Liew H.D. Oxygen transport to tissue by persistent bubbles: theory and simulations. J. Appl. Physiol. 1994, 77:2874-2878.
132. Van Liew H.D., Burkard M.E. High oxygen partial pressure in tissue delivered by stabilized microbubbles. Oxygen Transport to Tissue XVIII 1997, 395-401. Springer.
133. Johnson J.L., Dolezal M.C., Kerschen A., Matsunaga T.O., Unger E.C. In vitro comparison of dodecafluoropentane (DDFP), perfluorodecalin (PFD), and perfluoroctylbromide (PFOB) in the facilitation of oxygen exchange. Artif. Cells Blood Substit. Immobil. Biotechnol. 2009, 37:156-162.
134. Riess J.G. Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery. Artif. Cells Blood Substit. Immobil. Biotechnol. 2005, 33:47-63.
135. Remy B., Deby-Dupont G., Lamy M. Red blood cell substitutes: fluorocarbon emulsions and haemoglobin solutions. Br. Med. Bull. 1999, 55:277-298.
136. Lundgren C.E., Bergoe G.W., Tyssebotn I.M. Intravascular fluorocarbon-stabilized microbubbles protect against fatal anemia in rats. Artif. Cells Blood Substit. Immobil. Biotechnol. 2006, 34:473-486.
137. Lundgren C.E., Tyssebotn I.M. AWARD NUMBER: W81XWH-07-1-0011 TITLE: Development of a Minimal-Bulk Oxygen Delivery Product to Enhance Survival During Hemorrhagic Shock/Studies Regarding the Use of Perfluorocarbon-Derived Intravascular Microbubbles from Oxygen Transport Final Report to USAMRMC 2008.
138. Culp W.C., Woods S.D., Skinner R.D., Brown A.T., Lowery J.D., Johnson J.L., Unger E.C., Hennings L.J., Borrelli M.J., Roberson P.K. Dodecafluoropentane emulsion decreases infarct volume in a rabbit ischemic stroke model. J. Vasc. Interv. Radiol. 2012, 23:116-121.
139. Woods S.D., Skinner R.D., Ricca A.M., Brown A.T., Culp W.C. Progress in dodecafluoropentane emulsion as a neuroprotective agent in a rabbit stroke model. Mol. Neurobiol. 2013, 48(2):363-367.